Literature DB >> 15844960

Majusculoic acid, a brominated cyclopropyl fatty acid from a marine cyanobacterial mat assemblage.

John B Macmillan1, Tadeusz F Molinski.   

Abstract

The novel antifungal compound majusculoic acid was isolated from a cyanobacterial mat microbial community. The structure of majusculoic acid was solved by interpretation of mass spectrometric and NMR data and conversion to the corresponding methyl ester. Majusculoic acid exhibits antifungal activity against Candida albicans ATCC 14503 (MIC 8 microM).

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15844960     DOI： 10.1021/np049596k

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  10 in total

1.  Fatty Acids of Chthonomonas calidirosea, of a novel class Chthonomonadetes from a recently described phylum Armatimonadetes.

Authors:  M Vyssotski; K C-Y Lee; K Lagutin; J Ryan; X C Morgan; M B Stott
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

2.  Lyngbyoic acid, a "tagged" fatty acid from a marine cyanobacterium, disrupts quorum sensing in Pseudomonas aeruginosa.

Authors:  Jason Christopher Kwan; Theresa Meickle; Dheran Ladwa; Max Teplitski; Valerie Paul; Hendrik Luesch
Journal:  Mol Biosyst       Date:  2011-01-24

3.  Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria.

Authors:  George Chlipala; Shunyan Mo; Esperanza J Carcache de Blanco; Aiko Ito; Stanley Bazarek; Jimmy Orjala
Journal:  Pharm Biol       Date:  2009-01       Impact factor: 3.503

Review 4.  New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents.

Authors:  N M Carballeira
Journal:  Prog Lipid Res       Date:  2007-11-01       Impact factor: 16.195

5.  Novel cyclopropane fatty acids from the phospholipids of the Caribbean sponge Pseudospongosorites suberitoides.

Authors:  Néstor M Carballeira; Nashbly Montano; Jan Vicente; Abimael D Rodriguez
Journal:  Lipids       Date:  2007-03-14       Impact factor: 1.880

Review 6.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

Review 7.  Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology.

Authors:  Noora Barzkar; Saeid Tamadoni Jahromi; Hadi Bolooki Poorsaheli; Fabio Vianello
Journal:  Mar Drugs       Date:  2019-08-08       Impact factor: 5.118

8.  Total Synthesis and Anti-Inflammatory Bioactivity of (-)-Majusculoic Acid and Its Derivatives.

Authors:  Hong-Xiu Xiao; Qing-Xiang Yan; Zhi-Hui He; Zheng-Biao Zou; Qing-Qing Le; Ting-Ting Chen; Bing Cai; Xian-Wen Yang; Su-Lan Luo
Journal:  Mar Drugs       Date:  2021-05-21       Impact factor: 5.118

9.  Evaluating Marine Cyanobacteria as a Source for CNS Receptor Ligands.

Authors:  Andrea L Rague; Stacy-Ann J Parker; Kevin J Tidgewell
Journal:  Molecules       Date:  2018-10-17       Impact factor: 4.411

10.  Cyclopropane-Containing Fatty Acids from the Marine Bacterium Labrenzia sp. 011 with Antimicrobial and GPR84 Activity.

Authors:  Jamshid Amiri Moghaddam; Antonio Dávila-Céspedes; Stefan Kehraus; Max Crüsemann; Meryem Köse; Christa E Müller; Gabriele Maria König
Journal:  Mar Drugs       Date:  2018-10-08       Impact factor: 5.118
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.